Total submissions: 4
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Eurofins Ntd Llc |
RCV000726240 | SCV000343120 | uncertain significance | not provided | 2016-07-19 | criteria provided, single submitter | clinical testing | |
Labcorp Genetics |
RCV001087586 | SCV000656806 | likely benign | Episodic ataxia type 2; Developmental and epileptic encephalopathy, 42 | 2023-12-25 | criteria provided, single submitter | clinical testing | |
Gene |
RCV000357921 | SCV000723604 | likely benign | not specified | 2017-10-12 | criteria provided, single submitter | clinical testing | This variant is considered likely benign or benign based on one or more of the following criteria: it is a conservative change, it occurs at a poorly conserved position in the protein, it is predicted to be benign by multiple in silico algorithms, and/or has population frequency not consistent with disease. |
Prevention |
RCV003985318 | SCV004780958 | likely benign | CACNA1A-related disorder | 2020-04-29 | criteria provided, single submitter | clinical testing | This variant is classified as likely benign based on ACMG/AMP sequence variant interpretation guidelines (Richards et al. 2015 PMID: 25741868, with internal and published modifications). |